The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Self-citationFang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Self-citationThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,341
(2016) · Wiley eBooks · doi:10.1002/9781119000822 · Cited by 1,148
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Self-citationMaeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Self-citationHow much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question
Fojo, T., & Grady, C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp177 · Cited by 349
MAEDA, H. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.53 · Cited by 291
Self-citationIwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
Self-citation(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Self-citationMaeda, H., Ueda, M., Morinaga, T., & Matsumoto, T. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00382a012 · Cited by 225
Self-citationNagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Self-citationEnhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Seki, T., Fang, J., & Maeda, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01323.x · Cited by 179
Self-citationYasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
MAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 159
Self-citationWhy we're losing the war on cancer (and how to win it).
Leaf, C. (2004) · PubMed · Cited by 156
Maki, S., Konno, T., & Maeda, H. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<751::aid-cncr2820560409>3.0.co;2-y · Cited by 142
Self-citationYasuda, H., Nakayama, K., Watanabe, M., Suzuki, S., Fuji, H., Okinaga, S., Kanda, A., Zayasu, K., Sasaki, T., Asada, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1124 · Cited by 120
Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs
Maeda, H., Matsumoto, T., Konno, T., Iwai, K., & Ueda, M. (1984) · Journal of Protein Chemistry · doi:10.1007/bf01040499 · Cited by 115
Self-citationSiemens, D. R., Heaton, J. P. W., Adams, M. A., Kawakami, J., & Graham, C. H. (2009) · Urology · doi:10.1016/j.urology.2009.03.004 · Cited by 100
Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Self-citationTargeted Therapy for Advanced Colorectal Cancer — More Is Not Always Better
Mayer, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejme0809343 · Cited by 89
Fang, J. Q., Qin, H., Nakamura, H., Tsukigawa, K., Shin, T., & Maeda, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02178.x · Cited by 88
Self-citationSawa, T., Wu, J., Akaike, T., & Maeda, H. (2000) · PubMed · Cited by 86
Self-citationThe Human Cancer Genome Project—one more misstep in the war on cancer
Miklos, G. L. G. (2005) · Nature Biotechnology · doi:10.1038/nbt0505-535 · Cited by 76
Maeda, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.002 · Cited by 64
Self-citationDaruwalla, J., Nikfarjam, M., Greish, K. F., Malcontenti‐Wilson, C., Muralidharan, V., Christophi, C., & Maeda, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01619.x · Cited by 54
Self-citationNakamura, H., Fang, J. Q., Gahininath, B., Tsukigawa, K., & Maeda, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.025 · Cited by 51
Self-citationFang, J. Q., Qin, H., Seki, T., Nakamura, H., Tsukigawa, K., Shin, T., & Maeda, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185348 · Cited by 46
Self-citationNoguchi, A., Takahashi, T., Yamaguchi, T., Kitamura, K., Noguchi, A., Tsurumi, H., Takashina, K., & Maeda, H. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb00093.x · Cited by 32
Self-citationProtective Role of d -Amino Acid Oxidase against Staphylococcus aureus Infection
Nakamura, H., Fang, J. Q., & Maeda, H. (2012) · Infection and Immunity · doi:10.1128/iai.06214-11 · Cited by 29
Self-citationA New Tactic for the Treatment of Jaundice: An Injectable Polymer-Conjugated Bilirubin Oxidase
Kimura, M., Matsumura, Y., Miyauchi, Y., & Maeda, H. (1988) · Experimental Biology and Medicine · doi:10.3181/00379727-188-42747 · Cited by 28
Self-citationLimits to the Human Cancer Genome Project?
Chng, W. J. (2007) · Science · doi:10.1126/science.315.5813.762b · Cited by 20
Welcome clinical leadership at NICE
Lancet, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61249-0 · Cited by 16
Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
Oda, T., Sato, F., Yamamoto, H., et al. (1989) · PubMed · Cited by 11
Enhanced Permeability and Retention Effect in Relation to Tumor Targeting
Maeda, H. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch3 · Cited by 10
Self-citationYasuda, H., Nakayama, K., Watanabe, M., Suzuki, S., Kaneta, T., Asada, M., Takai, Y., Okinaga, S., Kanda, A., Yanagihara, K., et al. (2006) · Clinical Cancer Research · Cited by 9
Hochdörffer, K., Stefano, G. D., Maeda, H., & Kratz, F. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch47 · Cited by 1
Self-citation
Cited by
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Self-citationAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Metadata
- Authors
- Maeda, H.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 164
- Issue
- 2
- Pages
- 138-144
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1975341277
- Cited by
- 814
- References
- 42
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.